Published 1 month ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Iovance Biotherapeutics (NASDAQ:IOVA)

Summary by Ground News

Iovance Biotherapeutics, Inc. granted inducement stock options covering an aggregate of 97,700 shares of Iovance's common stock to twenty new, non-executive employees. Each stock option vests over a three-year period, with one-third of the shares vesting on the first anniversary of the employee's start date. The remaining shares vest in eight quarterly installments over the next two years.

0 Articles

All

Left

Center

Right

Benzinga

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4) - Iovance Biotherapeutics (NASDAQ:IOVA)

SAN CARLOS, Calif., March 22, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ:IOVA) ("Iovance" or the "Company"), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating lymphocyte (TIL) therapies for patients with cancer, today announced that on March 22, 2024 (the "Date of Grant"), the Company approved the grant of inducement stock options covering an aggregate of 97,700 sh…

1 month ago·New York, United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Stories disproportionately reported by the Left or the Right

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.